David Demirjian

Dr Demirjian is President of Midwest Bioprocessing Center and President and CEO of zuChem, Inc. Dr. Demirjian was previously President and Co-Founder of ThermoGen, Inc.—a bioprocessing company that pioneered several chiral biocatalysis technologies for pharmaceutical applications. He is a previous winner of the Research Director's Association of Chicago "Entrepreneur of the Year Award" (1997) and recipient of the U.S. SBA "Tibbets Award" for successful commercialization of technology developed under the Federal SBIR grant program. Dr. Demirjian became VP of Technology Strategy for MediChem Life Sciences after their acquisition of ThermoGen (May 2000) and was a Director until its acquisition by deCODE Genetics (May 2002). He holds a Ph.D. in Genetics from The University of Chicago and a B.S.A. from the University of Michigan.